RECURSION PHARMACEUTICALS, INC. Diluted Shares Outstanding (Weighted Average)
RECURSION PHARMACEUTICALS, INC. (RXRX) reported Diluted Shares Outstanding (Weighted Average) of 532.46 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-05
- RECURSION PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 532.46M shares, a 27.58% increase year-over-year.
- RECURSION PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 529.30M shares, a 31.42% increase year-over-year.
- RECURSION PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 521.86M shares, a 55.09% increase year-over-year.
- RECURSION PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 446.99M shares, a 58.18% increase year-over-year.
- RECURSION PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 447.45M shares, a 63.18% increase from fiscal 2024.
- RECURSION PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 274.21M shares, a 31.92% increase from fiscal 2023.
- RECURSION PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 207.85M shares, a 18.41% increase from fiscal 2022.
- RECURSION PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 175.54M shares, a 40.04% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 532.46M shares 10-Q · filed 2026-08-05 | 530.89M shares 10-Q · filed 2026-08-05 | 527.87M shares derived: average of 3 quarters · filed 2026-08-05 | 507.65M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 529.30M shares 10-Q · filed 2026-05-06 | 525.58M shares derived: average of 2 quarters · filed 2026-05-06 | 499.38M shares derived: average of 3 quarters · filed 2026-05-06 | 478.88M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 521.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 484.42M shares derived: average of 2 quarters · filed 2026-02-25 | 462.07M shares derived: average of 3 quarters · filed 2026-08-05 | 447.45M shares 10-K · filed 2026-02-25 |
| 2025-09-30 | 446.99M shares 10-Q · filed 2025-11-05 | 432.17M shares derived: average of 2 quarters · filed 2026-08-05 | 422.64M shares 10-Q · filed 2025-11-05 | 400.90M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 417.36M shares 10-Q · filed 2026-08-05 | 410.27M shares 10-Q · filed 2026-08-05 | 385.54M shares derived: average of 3 quarters · filed 2026-08-05 | 359.80M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 402.77M shares 10-Q · filed 2026-05-06 | 369.63M shares derived: average of 2 quarters · filed 2026-05-06 | 340.61M shares derived: average of 3 quarters · filed 2026-05-06 | 316.01M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | 336.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 309.54M shares derived: average of 2 quarters · filed 2026-02-25 | 287.09M shares derived: average of 3 quarters · filed 2026-02-25 | 274.21M shares 10-K · filed 2026-02-25 |
| 2024-09-30 | 282.58M shares 10-Q · filed 2025-11-05 | 262.39M shares derived: average of 2 quarters · filed 2025-11-05 | 253.45M shares 10-Q · filed 2025-11-05 | 245.74M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | 242.20M shares 10-Q · filed 2025-08-05 | 239.11M shares 10-Q · filed 2025-08-05 | 233.45M shares derived: average of 3 quarters · filed 2026-02-25 | 228.67M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | 236.02M shares 10-Q · filed 2025-05-05 | 229.08M shares derived: average of 2 quarters · filed 2026-02-25 | 224.16M shares derived: average of 3 quarters · filed 2026-02-25 | 218.48M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | 222.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 218.24M shares derived: average of 2 quarters · filed 2026-02-25 | 212.63M shares derived: average of 3 quarters · filed 2026-02-25 | 207.85M shares 10-K · filed 2026-02-25 |
| 2023-09-30 | 214.33M shares 10-Q · filed 2024-11-06 | 207.87M shares derived: average of 2 quarters · filed 2024-11-06 | 203.09M shares 10-Q · filed 2024-11-06 | 198.29M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | 201.42M shares 10-Q · filed 2024-08-08 | 198.96M shares 10-Q · filed 2024-08-08 | 192.94M shares derived: average of 3 quarters · filed 2025-02-28 | 188.06M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | 191.62M shares 10-Q · filed 2024-05-09 | 188.70M shares derived: average of 2 quarters · filed 2025-02-28 | 183.61M shares derived: average of 3 quarters · filed 2025-02-28 | 180.76M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | 185.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 179.61M shares derived: average of 2 quarters · filed 2025-02-28 | 177.14M shares derived: average of 3 quarters · filed 2025-02-28 | 175.54M shares 10-K · filed 2025-02-28 |
| 2022-09-30 | 173.44M shares 10-Q · filed 2023-11-09 | 172.82M shares derived: average of 2 quarters · filed 2023-11-09 | 172.12M shares 10-Q · filed 2023-11-09 | 171.55M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 172.21M shares 10-Q · filed 2023-08-08 | 171.46M shares 10-Q · filed 2023-08-08 | 170.92M shares derived: average of 3 quarters · filed 2024-02-29 | 170.32M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 170.69M shares 10-Q · filed 2023-05-08 | 170.27M shares derived: average of 2 quarters · filed 2024-02-29 | 169.69M shares derived: average of 3 quarters · filed 2024-02-29 | 161.86M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | 169.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 169.19M shares derived: average of 2 quarters · filed 2024-02-29 | 158.92M shares derived: average of 3 quarters · filed 2024-02-29 | 125.35M shares 10-K · filed 2024-02-29 |
| 2021-09-30 | 168.53M shares 10-Q · filed 2022-11-08 | 153.45M shares derived: average of 2 quarters · filed 2022-11-08 | 110.51M shares 10-Q · filed 2022-11-08 | 87.99M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | 138.36M shares 10-Q · filed 2022-08-09 | 81.02M shares 10-Q · filed 2022-08-09 | 61.14M shares derived: average of 3 quarters · filed 2023-02-27 | 51.31M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | 23.04M shares 10-Q · filed 2022-05-10 | 22.52M shares derived: average of 2 quarters · filed 2023-02-27 | 22.29M shares derived: average of 3 quarters · filed 2023-02-27 | 22.13M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | 22.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 21.92M shares derived: average of 2 quarters · filed 2023-02-27 | 21.83M shares derived: average of 3 quarters · filed 2023-02-27 | 21.78M shares 10-K · filed 2023-02-27 |
| 2020-09-30 | 21.82M shares 10-Q · filed 2021-11-10 | 21.74M shares derived: average of 2 quarters · filed 2021-11-10 | 21.70M shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 21.65M shares 10-Q · filed 2021-08-13 | 21.65M shares 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | 21.64M shares 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | 21.57M shares 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |